<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="[MASC]/data/written/1471-230X-2-21.anc" start="2082" end="2087" sStart="1988" offset="94" sid="null" wn="1" wnkey="use%2:34:01::" text="Comparison of results of patients with and without liver disease was done using t-tests of continuous variables and Fisher's exact test or x2 for categoric measures." />
    <s path="[MASC]/data/written/1471-230X-2-21.anc" start="7977" end="7981" sStart="null" offset="139" sid="null" wn="1" wnkey="true%3:00:00::" text="The prevalence of this association was found to be higher in our study than in other previous series [ 2 3 4 5 6 7 ] . The true prevalence could be even higher since liver enzyme profiles were not done in all patients." />
    <s path="[MASC]/data/written/1471-230X-2-21.anc" start="7977" end="7981" sStart="null" offset="139" sid="null" wn="1" wnkey="true%3:00:00::" text="The prevalence of this association was found to be higher in our study than in other previous series [ 2 3 4 5 6 7 ] . The true prevalence could be even higher since liver enzyme profiles were not done in all patients." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-230X-2-21.anc" start="7977" end="7981" sStart="null" offset="139" sid="r11.true.j.0461" wn="5" wnkey="true%5:00:00:typical:00" text="The prevalence of this association was found to be higher in our study than in other previous series [ 2 3 4 5 6 7 ] . The true prevalence could be even higher since liver enzyme profiles were not done in all patients." />
    <s path="[MASC]/data/written/1471-230X-2-21.anc" start="7977" end="7981" sStart="null" offset="139" sid="r11.true.j.0018" wn="1" wnkey="true%3:00:00::" text="The prevalence of this association was found to be higher in our study than in other previous series [ 2 3 4 5 6 7 ] . The true prevalence could be even higher since liver enzyme profiles were not done in all patients." />
    <s path="[MASC]/data/written/1471-230X-2-21.anc" start="7977" end="7981" sStart="null" offset="139" sid="null" wn="1" wnkey="true%3:00:00::" text="The prevalence of this association was found to be higher in our study than in other previous series [ 2 3 4 5 6 7 ] . The true prevalence could be even higher since liver enzyme profiles were not done in all patients." />
    <s path="[MASC]/data/written/1471-230X-2-21.anc" start="7977" end="7981" sStart="null" offset="139" sid="r11.true.j.0018" wn="1" wnkey="true%3:00:00::" text="The prevalence of this association was found to be higher in our study than in other previous series [ 2 3 4 5 6 7 ] . The true prevalence could be even higher since liver enzyme profiles were not done in all patients." />
    <s path="[MASC]/data/written/1471-230X-2-21.anc" start="9854" end="9860" sStart="null" offset="183" sid="null" wn="6" wnkey="severe%5:00:01:bad:00" text="An association of ENA response with liver disease has been described in children with autoimmune hepatitis, where anti-ENA-positive patients demonstrated more severe liver test abnormalities than those who were anti-ENA-negative [ 32 ] . In another study, a 15 % of patients with various chronic liver diseases were found to be anti-RNP positive [ 33 ] ." />
    <s path="[MASC]/data/written/1471-230X-2-21.anc" start="9854" end="9860" sStart="null" offset="183" sid="null" wn="1" wnkey="severe%5:00:00:intense:00" text="An association of ENA response with liver disease has been described in children with autoimmune hepatitis, where anti-ENA-positive patients demonstrated more severe liver test abnormalities than those who were anti-ENA-negative [ 32 ] . In another study, a 15 % of patients with various chronic liver diseases were found to be anti-RNP positive [ 33 ] ." />
    <s path="[MASC]/data/written/1471-230X-2-21.anc" start="9854" end="9860" sStart="null" offset="183" sid="r11.severe.j.0003" wn="1" wnkey="severe%5:00:00:intense:00" text="An association of ENA response with liver disease has been described in children with autoimmune hepatitis, where anti-ENA-positive patients demonstrated more severe liver test abnormalities than those who were anti-ENA-negative [ 32 ] . In another study, a 15 % of patients with various chronic liver diseases were found to be anti-RNP positive [ 33 ] ." />
    <s path="[MASC]/data/written/1471-230X-2-21.anc" start="9854" end="9860" sStart="null" offset="183" sid="null" wn="1" wnkey="severe%5:00:00:intense:00" text="An association of ENA response with liver disease has been described in children with autoimmune hepatitis, where anti-ENA-positive patients demonstrated more severe liver test abnormalities than those who were anti-ENA-negative [ 32 ] . In another study, a 15 % of patients with various chronic liver diseases were found to be anti-RNP positive [ 33 ] ." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-230X-2-21.anc" start="9854" end="9860" sStart="null" offset="183" sid="r11.severe.j.0339" wn="1" wnkey="severe%5:00:00:intense:00" text="An association of ENA response with liver disease has been described in children with autoimmune hepatitis, where anti-ENA-positive patients demonstrated more severe liver test abnormalities than those who were anti-ENA-negative [ 32 ] . In another study, a 15 % of patients with various chronic liver diseases were found to be anti-RNP positive [ 33 ] ." />
    <s path="[MASC]/data/written/1471-230X-2-21.anc" start="9854" end="9860" sStart="null" offset="183" sid="r11.severe.j.0003" wn="6" wnkey="severe%5:00:01:bad:00" text="An association of ENA response with liver disease has been described in children with autoimmune hepatitis, where anti-ENA-positive patients demonstrated more severe liver test abnormalities than those who were anti-ENA-negative [ 32 ] . In another study, a 15 % of patients with various chronic liver diseases were found to be anti-RNP positive [ 33 ] ." />
  </sentences>
</list>